Showing results (941-950 of 1,032) with videos related to

Sort By:
Pageof 104
Cancer Immunology, Immunotherapy : CII|May 29, 2023
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 studyMatteo Santoni, Zin W Myint, Thomas Büttner, et al.
Pain|May 7, 2016
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendationsRobert R Edwards, Robert H Dworkin, Dennis C Turk, et al.
Cancer Research|May 13, 2021
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 InhibitionGeorge Sharbeen, Joshua A McCarroll, Anouschka Akerman, et al.
Iscience|February 22, 2024
Airway inflammation accelerates pulmonary exacerbations in cystic fibrosisTheodore G Liou, Natalia Argel, Fadi Asfour, et al.
Pain|June 11, 2020
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerationsShannon M Smith, Robert H Dworkin, Dennis C Turk, et al.
Pain|September 12, 2021
Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendationsBethea A Kleykamp, Robert H Dworkin, Dennis C Turk, et al.
The Journal of Pain|December 18, 2019
Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT RecommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pageof 104